Gopi Suvanam of InvestWorks told CNBC-TV18, “I am in general positive about pharma sector. It is sort of a defensive that people could play around with. However, Sun Pharma it is highly news based so I don’t want to take a call at the moment."
He further added, "If some investor is looking to build a defensive portfolio definitely Sun Pharma should be one of the picks that he should add to that portfolio." On June 3, Sun Pharmaceutical Industries closed at Rs 1,017.50, down Rs 28.00, or 2.68 percent. It has touched an intraday high of Rs 1,048.00 and an intraday low of Rs 990.Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
